Cleared Traditional

K944152 - PARI BABY

K944152 is an FDA 510(k) clearance for PARI BABY, manufactured by Pari Holding Co.. The device is a Class 2 Anesthesiology device with product code CAF cleared through the Traditional 510(k) pathway after a 88-day FDA review.

K944152 · Pari Holding Co. · Anesthesiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 1994
Decision
88d
Days
Class 2
Risk

K944152 is an FDA 510(k) clearance for the PARI BABY. Classified as Nebulizer (direct Patient Interface) (product code CAF), Class II - Special Controls.

Submitted by Pari Holding Co. (Richmond, US). The FDA issued a Cleared decision on November 18, 1994 after a review of 88 days - a notably fast clearance cycle.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.5630 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Pari Holding Co. devices

FDA 510(k) Submission Details - K944152

510(k) Number K944152 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 22, 1994
Decision Date November 18, 1994
Days to Decision 88 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary Statement
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
52d faster than avg
Panel avg: 140d · This submission: 88d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

CAF Device Classification - Class 2, Special Controls

Product Code CAF Nebulizer (direct Patient Interface)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.5630
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - CAF Nebulizer (direct Patient Interface)

All 248
Devices cleared under the same product code (CAF) and FDA review panel - the closest regulatory comparables to K944152.
3002 AEROMAX
K942444 · Medical Industries America, Inc. · Mar 1995
4003 AEROLITE
K942208 · Medical Industries America, Inc. · Feb 1995
CAREPAK
K942350 · Precision Medical, Inc. · Dec 1994
UNIHEART
K943600 · Vortran Medical Technology 1, Inc. · Oct 1994
AUTONEB ACCESSORY CROSS (AAC)
K944643 · Vortran Medical Technology 1, Inc. · Oct 1994
AUTONEB BREATH ACTUATED CONTROLLER AND ACCESSORY KIT
K935693 · Vortran Medical Technology 1, Inc. · Aug 1994